Biopharmaceutical research companies, working in collaboration with academia, government researchers, patient organizations and others in the innovation ecosystem, are applying new scientific approaches and evolving knowledge of disease to bring new solutions to patients who face mental disorders such as anxiety, depression, schizophrenia or substance use disorders.